TESTIMONY
OF
MICHAEL
MOODIE
President of the Chemical and Biological
Arms Control Institute
CURRENT
AND FUTURE WEAPONS OF
MASS DESTRUCTION THREATS
Hearing
of the International Security, Proliferation and
Federal Services Subcommittee of the
Senate Governmental Affairs Committee
November
7, 2001
Mr. Chairman, Members of
the Committee,
I appreciate the opportunity to appear before the Subcommittee as it
addresses “Current and Future Weapons of Mass Destruction (WMD) Proliferation
Threats” and considers the effectiveness of export controls in meeting
the threat. My remarks are drawn from work conducted over the
last six years by the Chemical and Biological Arms Control Institute
(CBACI) on issues related to chemical and biological weapons and CBRN
terrorism. My remarks today will focus on chemical and, especially,
biological weapons threats.
I would like to address three inter-related issues: the need for
better threat assessments; the linkage between state and non-state threats;
and the need for a strategic response in which export controls continue
to play an important role.
My starting point is the recommendation of the Gilmore Commission (The
Advisory Panel to Assess Domestic Response Capabilities for Terrorism
Involving Weapons of Mass Destruction) that we must improve our threat
assessments. This is true not only with respect to the threat
of terrorism but also for the challenge of proliferation at the state
level.
Traditionally, threat assessments have been overly simplistic.
They have tended to focus on only a single factor such as the agent
that might be used or the motivations of the state or terrorist who
might use them. In addition, threat assessments have emphasized
vulnerabilities rather than risks, which are a combination of vulnerability
and likelihood.
The emphasis on vulnerabilities that derives from a focus only on a
single factor such as the agent has several drawbacks:
First, vulnerability assessments,
especially those focused on BW, portray dangers that are virtually infinite.
As a result they provide no criteria or metric against which to plan.
The result is either policy paralysis in the face of an overwhelming
challenge or pressure to commit enormous funds that will never be enough.
Second, they foster worst
case thinking that skews resources toward high-consequence, low probability
contingencies.
Third, vulnerability assessments
transform “what ifs” into tangible contingencies. They provide
no sense of whether what is theoretically possible in fact matches the
reality of what is likely to happen.
An example of this kind of vulnerability assessment is one that often
focuses on the agent smallpox. A scenario is posited that begins,
“Assume a terrorist has smallpox…,” and it proceeds to describe events
that lead to a global smallpox pandemic. While it is possible
that use of smallpox could have such consequences, the assessment itself
says nothing about the likelihood of such an occurrence. And yet,
appreciating the likelihood of an event is critical to effective policy
planning. Where, for example, would the terrorist get the smallpox
initially? Unlike anthrax, smallpox is not present in nature since
it was eradicated as an infectious disease by the World Health Organization.
There are potential sources of smallpox, but the scenario of the kind
posited above does not address the issue of acquistion. Would
not the issue of availability have some bearing on the likelihood of
that particular scenario and, hence, be of interest and concern to a
decision maker?
Conducting more complex threat assessments is not easy. It demands
good intelligence and creative analysis. But a better threat assessment
will do three things.
First, it describes a “threat
envelope” that identifies the most plausible contingencies. Such
contingencies may be far-reaching. We have tended to focus on smallpox
and anthrax, for example, to the detriment of looking in detail at the
implications of use of many other potential agents. These could
include such traditional BW agents as plague or hemorrhagic fevers, simple
agents such as salmonella, e-coli, or industrial chemicals, or more exotic
possibilities that lie at the edge of advancing science and technology.
Second, it provides a means to identify those contingencies that require
hedging, in that, due to the severity of their consequences, some preparation
for them should be undertaken, even if they are relatively unlikely.
The combination of the threat envelope and the hedging contingencies should
give policy makers some measure for making decisions regarding policy
priorities and resource allocations.
Third, a good threat assessment will highlight the fact that the threat
is not unidimensional; rather, it is composed of several elements, including
Who: the actor—his motivations, intentions regarding
casualties, and capabilities
What: the agent
Where: the target
How: issues regarding the mode of attack, such as the dissemination
mechanism, and other operational considerations.
Each of these elements,
in turn, entails a significant array of possibilities. The key
to successful threat assessment is disaggregating the threat into these
component elements and assessing the possibilities that various combinations
of them produce. Some combinations of factors will yield significant
consequences; others will produce no consequences at all.
Historical examples illustrate how the various elements that make up
the threat interact to produce varying results. The Rajneeshis
in Oregon in the mid-1980s, for example, combined the goal of incapacitating
but not killing a significant number of people with a relatively common
agent (salmonella) and simple delivery system (pouring the agent on
salad bars) to produce a reasonably effective outcome (from their perspective).
In contrast, the Aum Shinrikyo was motivated to take mass casualties,
selected an appropriate target, and committed both considerable money
and scientific effort to the enterprise. It only had access, however,
to an attenuated strain of anthrax and its attempts to use biological
weapons were totally unsuccessful.
This approach to threat assessment leads to important findings that
should inform policy decisions.
First, a key relationship
exists between the degree of risk and the level of casualties desired
in an attack. This relationship, however, is not the straightforward
one that higher risk is associated with catastrophic casualty scenarios.
Indeed, the degree of risk declines as the level of desired casualties
increases, insofar as it becomes less likely.
Second, despite the low
probability of catastrophic attacks in the United States, there is still
ample cause for concern because we do not know how “massive” a mass
attack has to be. Worst-case scenarios need not happen to stress
the response system to the point of collapse. It is unlikely that
any regional or local response system, and perhaps even a national one,
will be capable of dealing with an attack that produces catastrophic
levels of casualties. But it is critical to raise the systems’
“breakpoints” by expanding capacity on a realistic basis to deal with
low-to-middle size CBW incidents. Moreover,
the danger and harm inherent in the use of chemical and, especially,
biological weapons is not limited to physical casualties. As we
have seen with the anthrax attacks, psychological impacts and social
and economic disruption are also potentially severe.
Third, the connections between
states with CBW programs and non-state actors warrant increased attention.
State-sponsored terrorists are among the few actors who could assemble
the requisite resources, skills, and materials to conduct a successful
attack in the United States that produces mass casualties. Linkages
between states and non-state actor could also take less direct forms,
such as terrorists’ employment of scientists who once worked in a state
program.
The events of September 11 and the subsequent anthrax attacks suggest
that the state-non-state actor connection is more important than ever
before. Analysts have tended to conceptualize and address the state
CBW proliferation challenge and chemical and biological terrorism along
separate tracks. Today, however, we must appreciate that we confront
a new challenge that is neither war nor terrorism as we have known them.
The distinction between the two has become blurred; in fact, war and terrorism
have become inextricably linked as has been demonstrated by the fact that
Osama bin Laden has both depended on and provided support to various national
governments. Our challenge is to see the problem as a whole.
We do not confront terrorism as we have witnessed it for the last 30 years,
that is, the discrete use of violence to achieve defined, limited political
objectives. Rather, our adversaries have declared war on the West,
and the United States in particular, and they are using terrorist tactics
as part of their campaign. And we confront an adversary that is
not a state but, nevertheless, has chemical and biological weapons potential
(at a minimum). State involvement, however, cannot be ruled out.
Press accounts have raised the possibility that the anthrax used in the
recent attacks can perhaps be linked to weapons programs in Iraq, the
former Soviet Union, or some other states pursuing a CBW capability (including
North Korea, Syria, or Libya). These reports may be true.
But they still highlight the need to understand better the links between
states and non-state actors who may be joined by a common interest in
chemical and biological weapons.
As this war unfolds, then, the United States may find itself at war against
one or more CBW-armed adversaries, whether state or non-state. How
do they think about the strategic and tactical utility of chemical, and
especially biological weapons? Their willingness to resort to such
capabilities depends, of course, on their strategic objectives.
Certainly, CBW’s role in asymmetric strategies of adversaries who seek
to avoid direct confrontations with overwhelming U.S. conventional military
power is an important consideration. But saying CBW capabilities
will be part of an asymmetric strategy is not enough. Different
strategic goals point to different CBW uses. A number of alternative
possibilities – each of which has both a limited and ultimate form – suggest
themselves as examples:
The desire to generate fear among the U.S. population, ultimately
pushing such fear to the point that it raises questions about the
integrity of U.S. society;
Slowing military action, or ultimately crippling U.S. strategies,
for example, that depend on power projection and coalition warfare;
or
Disrupting the U.S. economy, or ultimately undermining it by attacking
such critical components as the agricultural sector (a threat that
has received insufficient attention) or the financial centers of the
country.
The importance of understanding the strategic objective, whether of
the leadership of a terrorist group or of a nation-state, underlines
the need for better intelligence about and analysis of the strategic
cultures of our adversaries.
What does this approach
to defining the threat suggest about the needs for responding effectively
to that threat?
First, because the threat is multidimensional and complex, an effective
response must be strategic in nature. Effective action depends
on the existence of a strategy that – for both the military and domestic
defense dimensions – defines the contribution of each individual tool
of policy, relates them to one another, and integrates them in such
a way that they all work together toward the achievement of defined
goals and objectives.
A strategic response addresses requirements that span a spectrum: deterrence-prevention-defense-preparedness-response.
Today, to perform each of these strategic missions effectively, difficult
challenges must be overcome. Although there is a temptation to
rely on deterrence, for example, because the problem has often looked
too hard, the concept of deterrence cannot be translated easily from
its Cold War context. We need to understand better the requirements
of deterrence and how to do it in the current, more complex environment.
Similarly, effective responses – whether on the battlefield or in terms
of homeland defense – demand meeting both short-term needs such as adapting
military concepts of operations or upgrading the public health systems,
and long-term measures, including an effective research and development
program.
Second, a strategic response is also a multifaceted response.
A range of tools must be exploited. These include intelligence,
defenses (both passive and active), diplomacy, legal measures, preparedness
efforts, financial measures, and military options. Arms control
is also important, but, particularly with respect to biological weapons,
classic multilateral arms control (of the kind reflected in the Chemical
Weapons Convention) is unlikely to yield significant results.
The combination of politics, science and technology, and treaty language
that surrounds the Biological Weapons Convention (BWC) and efforts to
negotiate a legally binding protocol to the BWC argue for an approach
that goes beyond the traditional modalities of arms control to new ways
of thinking about how to strengthen the Convention and the norm against
BW which the treaty embodies.
Export controls also have an important role to play, but it is not necessarily
the traditional contribution of the past. Export control
regimes – which do not really control but rather regulate through licensing
systems – can be effective in delaying the acquisition of sensitive
technologies, but in the longer term they cannot realistically be expected
to stop the transfer of technology that may be used for weapons purposes,
particularly since so much of that technology also has legitimate commercial,
medical, and other uses. If Iraq was capable of assembling the
necessary materials and equipment for a robust CBW program as much as
15 years ago, how much more difficult will it be to deny access to technology
to a determined player in an era of rapidly expanding knowledge and
accelerating global dissemination of capabilities?
But this does not mean that export controls should be abandoned; they
perform other functions. Regulation through export controls facilitates
the global dissemination of materials and equipment. By defining
the rules of the game by which companies must abide, for example, export
controls is easier for those companies to engage in international trade
and cooperation. As Brad Roberts, chair of the CBACI Research
Council, has argued, export controls can, in fact, be trade enablers
rather than trade constraints. It is this role for export controls
that should be emphasized in the future. At the same time, the
United States must maintain open markets and avoid neoprotectionist
practices that deny or severely limit access to markets or appropriate
technology which would make key states less inclined to pursue cooperative
measures.
Each tool of policy contributes something to an effective response to
the CBW proliferation challenge. But each tool also has shortcomings
that must be overcome, and none of them constitutes a silver bullet
that provides the total answer. Rather, for an effective response,
the individual tools of policy – including export controls – must be
integrated into a coherent strategic framework that realizes the synergies
among the various tools of strategy, and facilitates tradeoffs among
them so that they do not work at cross-purposes but maximize their potential
contribution.
The CBW threat is not static and will continue to evolve. Changing actors
and evolving technology – especially in biology-related areas – will
be major drivers of such change. In this fluid environment, like
the offense-defense relationship in military affairs, the relationship
between CBW proliferators – whether state or non-state – and responders
is constantly in flux. It is not always possible to state precisely
at any given time how the balance stands between them. The important
point, however, is that certainty will only be achieved if we take ourselves
out of the game and do nothing. Then we are certain to lose.
It is not a loss that the nation or the world can afford.